📰 Cardlytics Platform News
Cardlytics Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cardlytics Platform. Real-time updates on events, politics, business and more.
June 13, 2023
Fund 1 Investments LLC bought a new position in Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 25,000 shares of the company’s stock, valued at approximately $144,000. Fund 1 Investments LLC owned approximately 0.08% of Cardlytics […]
June 5, 2023
Antipodean Advisors LLC lessened its stake in Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) by 86.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 75,000 shares of the company’s stock after selling 465,400 shares during the quarter. Cardlytics accounts for about 1.4% of Antipodean […]
May 16, 2023
Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) saw a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 5,140,000 shares, a decline of 9.5% from the April 15th total of 5,680,000 shares. Based on an average daily trading volume, of 2,360,000 shares, the short-interest ratio is […]
May 2, 2023
Cardlytics (NASDAQ:CDLX – Get Rating) is scheduled to announce its earnings results after the market closes on Thursday, May 4th. Analysts expect the company to announce earnings of ($0.49) per share for the quarter. Cardlytics has set its Q1 2023 guidance at EPS.Investors that are interested in registering for the company’s conference call can do […]
May 1, 2023
Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 5,680,000 shares, an increase of 19.3% from the March 31st total of 4,760,000 shares. Based on an average daily volume of 2,230,000 shares, the days-to-cover ratio is presently […]
May 1, 2023
Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 5,680,000 shares, a growth of 19.3% from the March 31st total of 4,760,000 shares. Based on an average trading volume of 2,230,000 shares, the short-interest ratio is presently […]
April 30, 2023
Brooktree Capital Management lessened its holdings in Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) by 57.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,268 shares of the company’s stock after selling 55,252 shares during the period. Brooktree Capital Management owned approximately 0.12% of […]
April 23, 2023
Cardlytics (NASDAQ:CDLX – Get Rating) and AdTheorent (NASDAQ:ADTH – Get Rating) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and analyst recommendations. Volatility & Risk Cardlytics has a beta of 1.74, meaning […]
April 18, 2023
Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 4,760,000 shares, an increase of 29.3% from the March 15th total of 3,680,000 shares. Based on an average daily trading volume, of 2,140,000 shares, the […]
April 3, 2023
Cardlytics, Inc. (NASDAQ:CDLX – Get Rating) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 3,680,000 shares, a growth of 9.5% from the February 28th total of 3,360,000 shares. Based on an average daily volume of 708,400 shares, the days-to-cover […]